Total Funding
1
Total FundingSeries A raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3530412
Signature Therapeutics is focused on creating novel medicines to improve upon the therapeutic utility of existing drugs.
Robert V. Gunderson, Jr: DirectorPast Role: University of Chicago, Executive Editor
Wesley D. Sterman: Founder, President and Chief Executive OfficerPast Role: Menlo Ventures, Led
About the Company
Signature Therapeutics, Inc. (formerly PharmacoFore) is a privately-held biopharmaceutical company focused on creating novel medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications. They have developed a resilient business model for creating
long-term value by pursuing a portfolio of carefully chosen programs where in drug activity is based upon known mechanisms-of-action and where human proof-of-concept can be achieved early in clinical trials. Their initial focus is on medicines for the central nervous system (CNS).
